Skip to content

Upper eyelid blepharoplasty investigating 3D and functional outcomes

Upper eyelid blepharoplasty investigating 3D and functional outcomes - Upper eyelid blepharoplasty investigating 3D and functional outcomes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44420
Enrollment
54
Registered
2017-11-17
Start date
2018-02-20
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blefarochalasis, huidoverschot van de bovenoogleden blepharochalasis excess skin upper eyelid

Interventions

Patients undergo a blepharoplasty.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Blepharochalasis of both eyes - Age between 30 and 60 - Caucasian - Both male and female patients are included - Correction of vision between -6 and +6 - Vision of 0.5 or better (with correction) - Fluent in Dutch - Legally capable

Exclusion criteria

Exclusion criteria: - Protruding medial fat compartment - Ocular trauma in past - Trauma of the orbital region in the past - A medical history of eyelid surgery or surgery in the region of the eyebrows. - Any current ophthalmic disease that could interfere with the ophthalmic tests - Horner syndrome - Blepharoptosis - Graves* disease - Myasthenia Gravis - Recent (in the past 6 months) botulin toxin treatment in the upper face - Nasolacrimal duct obstruction - Epilepsy - Retinal defects/diseases that cause visual field defects

Design outcomes

Primary

MeasureTime frame
The primary endpoint is orbital change in volume.

Secondary

MeasureTime frame
Secondary outcomes are electrical activity of the frontal and orbicularis oculi muscles, peripheral vision, presence and severity of dry eyes, quality of life and wellbeing.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)